+499.5%
MRNA vs JBLU
-14.6%
+514.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | JBLU | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.4% | -2.7% | -2.3% |
| 7D | +5.5% | -3.5% | +9.0% | +6.3% |
| 30D | +158.7% | -27.2% | +185.9% | +183.8% |
| 3M | +182.1% | -4.3% | +186.5% | +180.0% |
| 6M | +151.8% | -8.3% | +160.1% | +147.9% |
| YTD | +393.6% | +1.8% | +391.8% | +346.1% |
| 1Y | +499.5% | -9.0% | +508.5% | +465.8% |
| All | +499.5% | -14.6% | +514.0% | +465.8% |
Cumulative growth
Daily Returns
Daily percentage return beside JBLU.
Daily Out/Under-Performance
Portfolio return minus JBLU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × JBLU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded JBLU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling